Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?

Ece H, Mehmet E, Cigir BA, Yavuz D, Muammer K, Cumhur G, Mustafa H, Sevki C, Fusun S, Gokhan OA.

Contemp Oncol (Pozn). 2013;17(1):51-7. doi: 10.5114/wo.2013.33774.

2.
3.

[Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].

Rink T, Dembowski W, Schroth HJ, Klinger K.

Nuklearmedizin. 2000 Aug;39(5):133-8. German.

PMID:
10984889
4.

Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases.

Lima PC, Moura Neto A, Tambascia MA, Zantut Wittmann DE.

ISRN Endocrinol. 2013 May 25;2013:673146. doi: 10.1155/2013/673146.

6.

Hashimoto's thyroiditis following Graves' disease.

Umar H, Muallima N, Adam JM, Sanusi H.

Acta Med Indones. 2010 Jan;42(1):31-5.

7.

Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.

Sawicka B, Bossowski A, Szalecki M, Wysoka J, Koput A, Zelazowska-Rutkowska B, Tobolczyk J, Rogowski F, Łuba M.

J Pediatr Endocrinol Metab. 2010 Apr;23(4):345-54.

PMID:
20583539
8.

Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases.

Bradly DP, Reddy V, Prinz RA, Gattuso P.

Surgery. 2009 Dec;146(6):1099-104. doi: 10.1016/j.surg.2009.09.025.

PMID:
19958937
9.

[Differentiated thyroid carcinoma in previously manifested autoimmune thyroid disease].

Cirić J, Beleslin-Nedeljković B.

Srp Arh Celok Lek. 2005 Oct;133 Suppl 1:74-6. Review. Serbian.

10.

Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.

Mariotti S, Caturegli P, Barbesino G, Marinò M, Del Prete GF, Chiovato L, Tonacchera M, De Carli M, Pinchera A.

Clin Endocrinol (Oxf). 1992 Nov;37(5):415-22.

PMID:
1486691
12.

Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.

Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.

J Clin Pharm Ther. 2004 Apr;29(2):151-6.

PMID:
15068404
13.

Endothelin-1 levels in patients with disorders of the thyroid gland.

Tilly N, Schneider JG, Leidig-Bruckner G, Sommer U, Kasperk C.

Exp Clin Endocrinol Diabetes. 2003 Apr;111(2):80-4.

PMID:
12746758
14.

[Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].

Bossowski A, Czarnocka B, Stasiak-Barmuta A, Bardadin K, Urban M, Dadan J.

Endokrynol Pol. 2007 Jul-Aug;58(4):303-13. Polish.

PMID:
18058722
15.

Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.

Gakiopoulou H, Litsiou E, Valaris K, Balafoutas D, Patsouris E, Tseleni-Balafouta S.

Endocr J. 2010;57(8):693-9.

16.

Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.

Rieu M, Richard A, Rosilio M, Laplanche S, Ropion V, Fombeur JP, Berrod JL.

Clin Endocrinol (Oxf). 1994 Apr;40(4):529-35.

PMID:
8187321
17.
18.

[Characteristics of thyroid carcinoma in Grave's disease Hashimoto's thyroiditis and nodular goiter].

Filipović A, Paunović I.

Acta Chir Iugosl. 2003;50(3):135-9. Serbian.

PMID:
15179770
19.

Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders.

Bossowski A, Sawicka B, Szalecki M, Koput A, Wysocka J, Zelazowska-Rutkowska B.

J Pediatr Endocrinol Metab. 2010 Apr;23(4):369-77.

PMID:
20583542
20.
Items per page

Supplemental Content

Support Center